Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 6
1976 6
1977 8
1978 4
1979 2
1980 5
1981 5
1982 4
1983 8
1984 7
1985 7
1986 13
1987 27
1988 8
1989 7
1990 9
1991 6
1992 5
1993 4
1994 3
1995 3
1996 3
1997 2
1998 3
1999 1
2002 5
2003 1
2004 3
2005 2
2006 2
2007 8
2008 3
2009 2
2010 2
2011 3
2012 4
2013 4
2014 3
2015 5
2016 7
2017 7
2018 11
2019 10
2020 17
2021 12
2022 15
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. Olsen EA, et al. J Am Acad Dermatol. 2002 Sep;47(3):377-85. doi: 10.1067/mjd.2002.124088. J Am Acad Dermatol. 2002. PMID: 12196747 Clinical Trial.
An increased occurrence of pruritus and local irritation was observed with 5% topical minoxidil compared with 2% topical minoxidil. CONCLUSION: In men with AGA, 5% topical minoxidil was clearly superior to 2% topical minoxidil and placebo in increasing …
An increased occurrence of pruritus and local irritation was observed with 5% topical minoxidil compared with 2% topical minoxidil
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P, Srisuwanwattana P, Chalermroj N, Khunkhet S. Suchonwanit P, et al. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2257-2263. doi: 10.1111/jdv.15171. Epub 2018 Jul 20. J Eur Acad Dermatol Venereol. 2018. PMID: 29972712 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in men with androgenetic alopecia. ...RESULTS: At week 24, the combined solution of finasteride and minoxidil was signif …
OBJECTIVE: To compare the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil
Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia.
Pakhomova EE, Smirnova IO. Pakhomova EE, et al. Int J Mol Sci. 2020 Sep 6;21(18):6516. doi: 10.3390/ijms21186516. Int J Mol Sci. 2020. PMID: 32899959 Free PMC article. Clinical Trial.
MATERIALS AND METHODS: The study involved 69 men who were divided into 3 groups who received PRP therapy, minoxidil, and their combination. The clinical efficacy of the therapy was evaluated by the dynamics of morphometric of hairs. To assess cell proliferation antibodies …
MATERIALS AND METHODS: The study involved 69 men who were divided into 3 groups who received PRP therapy, minoxidil, and their combin …
Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.
Sánchez-Meza E, Ocampo-Candiani J, Gómez-Flores M, Herz-Ruelas ME, Ocampo-Garza J, Orizaga-Y-Quiroga TL, Martínez-Moreno A, Ocampo-Garza SS. Sánchez-Meza E, et al. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e806-e808. doi: 10.1111/jdv.18285. Epub 2022 Jun 16. J Eur Acad Dermatol Venereol. 2022. PMID: 35648446 Clinical Trial. No abstract available.
Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
Ghonemy S, Alarawi A, Bessar H. Ghonemy S, et al. J Dermatolog Treat. 2021 Mar;32(2):236-241. doi: 10.1080/09546634.2019.1654070. Epub 2019 Oct 21. J Dermatolog Treat. 2021. PMID: 31403367 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety of 5% topical minoxidil with 10% topical minoxidil and placebo in AGA treatment. ...No reported sexual dysfunction in all three groups. CONCLUSION: Five percent of topical minoxidil was moderately superior to 10% …
OBJECTIVE: To compare the efficacy and safety of 5% topical minoxidil with 10% topical minoxidil and placebo in AGA treatment. …
Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial.
Legiawati L, Suseno LS, Sitohang IBS, Yusharyahya SN, Pawitan JA, Liem IK, Kurniawati T, Ardelia A, Paramastri K. Legiawati L, et al. Stem Cell Res Ther. 2023 Aug 21;14(1):210. doi: 10.1186/s13287-023-03440-2. Stem Cell Res Ther. 2023. PMID: 37605227 Free PMC article. Clinical Trial.
OBJECTIVE: To investigate the efficacy of ADSC-CM combined with minoxidil for hair regeneration therapy in male AGA. METHODS: This study lasted for 6 weeks. ...Treatment side received 2 ml of ADSC-CM; the other side was given 2 ml of NaCl 0.9% as placebo. Patients applied …
OBJECTIVE: To investigate the efficacy of ADSC-CM combined with minoxidil for hair regeneration therapy in male AGA. METHODS: This st …
Ketoconazole shampoo: effect of long-term use in androgenic alopecia.
Piérard-Franchimont C, De Doncker P, Cauwenbergh G, Piérard GE. Piérard-Franchimont C, et al. Dermatology. 1998;196(4):474-7. doi: 10.1159/000017954. Dermatology. 1998. PMID: 9669136 Clinical Trial.
METHOD: The effect of 2% KCZ shampoo was compared to that of an unmedicated shampoo used in combination with or without 2% minoxidil therapy. RESULTS: Hair density and size and proportion of anagen follicles were improved almost similarly by both KCZ and minoxidil r …
METHOD: The effect of 2% KCZ shampoo was compared to that of an unmedicated shampoo used in combination with or without 2% minoxidil
Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial.
Asilian A, Farmani A, Saber M. Asilian A, et al. J Cosmet Dermatol. 2024 Mar;23(3):949-957. doi: 10.1111/jocd.16086. Epub 2023 Nov 29. J Cosmet Dermatol. 2024. PMID: 38031516 Clinical Trial.
AIM: To compare the effectiveness and safety of topical minoxidil as a first-choice treatment of androgenetic alopecia versus 1 mg daily oral minoxidil. ...Therefore, 1 mg oral minoxidil may be as effective and safe as standard topical minoxidil in fem …
AIM: To compare the effectiveness and safety of topical minoxidil as a first-choice treatment of androgenetic alopecia versus 1 mg da …
275 results